Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 801-825 of 958 matching filings.

Per page
25
Current page
33
8-K File 000-51967

FORM 8-K

Filing date
14 Mar 2012
Reporting date
14 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
13 Mar 2012
Reporting date
13 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
06 Mar 2012
Reporting date
29 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

RAAB ANNUAL GRANT

Filing date
03 Feb 2012
Reporting date
01 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

LAPORTE ANNUAL GRANT

Filing date
02 Feb 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OCLASSEN ANNUAL GRANT

Filing date
02 Feb 2012
Reporting date
01 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SOLOWAY ANNUAL GRANT

Filing date
02 Feb 2012
Reporting date
01 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SINGH ANNUAL GRANT

Filing date
02 Feb 2012
Reporting date
01 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

WORTZMAN ANNUAL GRANT

Filing date
02 Feb 2012
Reporting date
01 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
02 Feb 2012
Reporting date
01 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

LAPORTE ANNUAL GRANT

Filing date
26 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
26 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

EHRLICH GRANT

Filing date
25 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KILEY GRANT

Filing date
25 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

RUEGSEGGER GRANT

Filing date
25 Jan 2012
Reporting date
24 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-51967

FORM 8-K AMENDMENT

Filing date
11 Jan 2012
Reporting date
06 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
09 Jan 2012
Reporting date
06 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KILEY GIFT

Filing date
29 Dec 2011
Reporting date
28 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
21 Dec 2011
Reporting date
21 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-51967

FORM 8-K

Filing date
16 Dec 2011
Reporting date
13 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-81821

SC 13D/A

Filing date
08 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SINGH DEC 2011

Filing date
05 Dec 2011
Reporting date
05 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

SOLOWAY DEC 2011

Filing date
05 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

KENNEDY DEC 2011

Filing date
05 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .